Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial.
Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Liu L, Zhang T, Du L, Chen W, Shyr Y, Yin W, Li J, He J, Wang L. Liang J, et al. Ann Oncol. 2017 Apr 1;28(4):777-783. doi: 10.1093/annonc/mdx009. Ann Oncol. 2017. PMID: 28137739 Free article. Clinical Trial.
[Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X, Zhou ZM, Bi N, Wang JB, Ran JT, Hui ZG, Liang J, Feng QF, Chen DF, Xiao ZF, Lyu JM, Wang XZ, Wang X, Zhang T, Deng L, Wang WQ, Wang LH. Dong X, et al. Among authors: liang j. Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):446-451. doi: 10.3760/cma.j.issn.0253-3766.2018.06.009. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29936771 Chinese.
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
Ni WJ, Deng W, Xiao ZF, Zhou ZM, Wang X, Chen DF, Feng QF, Liang J, Lyu JM, Bi N, Deng L, Zhang T, Wang WQ, Xue Q, Gao SG, Mu JW, Mao YS, Wang DL, Zhao J, Gao YS, Huang JF, Tan FW, Zhao L, Lyu F, Zhang GC. Ni WJ, et al. Among authors: liang j. Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):295-302. doi: 10.3760/cma.j.issn.0253-3766.2019.04.010. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31014056 Chinese.
[Study on safety of adjuvant radiotherapy concurrent with weekly chemotherapy for stage ⅡB-ⅣA esophageal carcinoma after radical resection].
Ni WJ, Yu SF, Yang JS, Zhang WC, Zhou ZM, Zhang HX, Chen DF, Feng QF, Lyu JM, Liang J, Wang XZ, Wang X, Deng L, Wang WQ, Zhang T, Bi N, Xiao ZF. Ni WJ, et al. Among authors: liang j. Zhonghua Zhong Liu Za Zhi. 2019 Jun 23;41(6):415-420. doi: 10.3760/cma.j.issn.0253-3766.2019.06.004. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31216826 Chinese.
[Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
Wang JB, Jiang W, Ji Z, Cao JZ, Liu LP, Men Y, Xu C, Wang XZ, Hui ZG, Liang J, Lyu JM, Zhou ZM, Xiao ZF, Feng QF, Chen DF, Zhang HX, Yin WB, Wang LH. Wang JB, et al. Among authors: liang j. Zhonghua Zhong Liu Za Zhi. 2016 Aug;38(8):607-14. doi: 10.3760/cma.j.issn.0253-3766.2016.08.008. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27531481 Chinese.
[Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy].
Li C, Tan LJ, Liu X, Han WM, Gao LR, Wang SJ, Zhou ZM, Feng QF, Chen DF, Liang J, Lyu JM, Wang WQ, Hui ZG, Wang LH, Wang X, Liu WY, Deng L, Wang JY, Zhai YR, Zhang T, Bi N, Xiao ZF. Li C, et al. Among authors: liang j. Zhonghua Zhong Liu Za Zhi. 2021 Jun 23;43(6):678-684. doi: 10.3760/cma.j.cn112152-20201031-00952. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34289560 Chinese.
[No title available]
[No authors listed] [No authors listed] PMID: 34701489
18,139 results
You have reached the last available page of results. Please see the User Guide for more information.